# Preop fSRS for Resectable Brain Metastases

> **NCT05267587** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 49 (actual)

## Conditions studied

- Brain Metastases
- Brain Lesion

## Interventions

- **RADIATION:** Hypofractionated Stereotactic Radiosurgery

## Key facts

- **NCT ID:** NCT05267587
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-11
- **Primary completion:** 2025-05-29
- **Final completion:** 2026-08-21
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05267587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05267587, "Preop fSRS for Resectable Brain Metastases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05267587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*